Delinquent Medical Service Accounts at Brooke Army Medical Center Need Additional Management Oversight

Abstract

Our objective was to determine whether the Military Services and selected military medical treatment facilities were effectively managing medical service accounts that were more than 180 days delinquent by transferring the debt to the appropriate debt collection agency or actively pursuing collection. This is the first in a series of reports concerning medical service accounts (MSAs). This report provides the results of our review performed at U.S. Army Brooke Army Medical Center (BAMC). We reviewed the 25 highest dollar delinquent MSAs valued at $11.0 million. BAMC Uniform Business Office (UBO) management did not effectively manage delinquent MSAs. As of May 29, 2013, BAMC UBO management had 15,106 outstanding MSAs, valued at $73.1 million. The accounts were more than 180 days delinquent but had not been transferred to the U.S. Treasury. BAMC UBO management did not transfer 24 of 25 accounts, valued at $10.4 million, to the U.S. Treasury for collection after the account was 180 days delinquent. Further, BAMC UBO management did not actively pursue collection for 20 of the delinquent MSAs, valued at $8.8 million. This occurred because, among other reasons, BAMC UBO management did not have a process in place to monitor and notify staff of MSAs needing follow-up.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 13, 2014
Accession Number
ADA608835

Entities

Organizations

  • Office of the Inspector General, U.S. Department of Defense

Tags

DTIC Thesaurus Topics

  • Air Force
  • Business Administration
  • Command And Control
  • Commerce
  • Department Of Defense
  • Financial Management
  • Governments
  • Health
  • Health Care
  • Health Services
  • Hospitals
  • Law
  • Medical Personnel
  • Military Hospitals
  • Military Medicine
  • Payment
  • Therapy

Readers

  • Data Mining and Knowledge Discovery.
  • Government Contracting/Procurement.
  • Parasitology and Pharmacology of Malaria.